Infant meningoencephalitis caused by yellow fever vaccine virus transmitted via breastmilk;Meningoencefalite causada pelo vírus vacinal da febre amarela transmitido pelo leite materno

Jornal de Pediatria

Volumn 87, Issue 3, 2011, Pages 269-272

  Traiber, Cristiane ^a,b   Coelho Amaral, Priscila ^c   Fonteles Ritter, Valéria Raymundo ^c,d   Winge, Annelise ^c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Hospital da Crianca Conceicão   (Brazil)

^c GHC   (Brazil)

^d Hospital Materno Infantil Presidente Vargas   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; YELLOW FEVER VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BREAST MILK; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CONVULSION; FEMALE; HUMAN; INFANT DISEASE; MENINGOENCEPHALITIS; MOTHER; VIRUS TRANSMISSION; YELLOW FEVER;

BREAST FEEDING; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MENINGOENCEPHALITIS; MILK, HUMAN; YELLOW FEVER; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

EID: 79958764200     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.2067     Document Type: Article

References (13)

1. Ministério da Saúde do Brasil. Fundação Nacional de Saúde. Vigilância Epidemiológica. Eventos adversos sérios associados com a vacina 17D contra a Febre Amarela. Brasília: FUNASA, 2000. http://portal.saude.gov.br/portal/arquivos/pdf/ eventos-adversos-serios.pdf. Acesso: 01/07/2010.
2. Staples JE, Gershman M, Fischer M; Centers for Disease Control and Prevention. Yellow Fever Vaccine: recommendations of the Advisory Committee on Immunization Pratices (ACIP). MMWR Recomm Rep. 2010;59:1-27.
3. Guimard T, Minjolle S, Polard E, Fily F, Zeller H, Michelet C, et al. Short report: incidence of yellow fever vaccine-associated neurotropic disease. Am J Trop Med Hyg. 2009;81:1141-3.
4. Douce RW, Freire D, Tello B, Vásquez GA. A case of yellow fever vaccine-associated viscerotropic disease in Ecuador. Am J Trop Med Hyg. 2010;82:740-2.
5. Secretaria da Saúde do Estado do Rio Grande do Sul. Serviços: Febre Amarela. http://www.saude.rs.gov.br/wsa/portal/index.jsp? menu=serviço&cod=22246. Acesso: 09/08/2010.
6. Centers for Disease Control and Prevention (CDC). Transmission of yellow fever vaccine virus through breast-feeding - Brazil, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:130-2.
7. Lang J, Zuckerman J, Clarke P, Barret P, Kirkpatrick C, Blondeau C. Comparison of the immunogenicity and safety of two 17D yellow fever vaccines. Am J Trop Med Hyg. 1999;60:145-50.
8. Fernandes GC, Camacho LA, Sá Carvalho M, Batista M, de Almeida SM. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005. Vaccine. 2007;25:3124-8.
9. Feijó RB, Cunha J, Krebs LS. Vaccination schedule for childhood and adolescence: comparing recommendations. J Pediatr (Rio J). 2006;82:S4-14.
10. Mateo RI, Xiao SY, Travassos da Rosa AP, Lei H, Guzman H, Lu L, et al. Yellow fever 17-D vaccine is neurotropic and produces encephalitis in immunosuppressed hamsters. Am J Trop Med Hyg. 2007;77:919-24. (Pubitemid 351837842)
11. McMahon AW, Eidex RB, Marfin AA, Russell M, Sejvar JJ, Markoff L, et al. Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Vaccine. 2007;25:1727-34. (Pubitemid 46188373)
12. Chaves M, Riccio P, Patrucco L, Rojas J, Cristiano E. Longitudinal myelitis associated with yellow fever vaccination. J Neurovirol. 2009;15:348-50.
13. Ministério da Saúde do Brasil. Recomendação da Vacina Febre Amarela VFA (atenuada) em mulheres que estão amamentando. Nota Técnica No05/2010/CGPNI/DEVEP/SVS/MS. http://portal.saude.gov.br/ portal/arquivos/pdf/nota-tecnica-05-2010-cgpni.pdf. Acesso: 09/08/2010.